Mordechai Algrably
Chief Executive Officer chez REKAH PHARMACEUTICAL INDUSTRY LTD.
Fortune : 7 M $ au 31/03/2024
Profil
Mordechai Algrably is the founder of Ophir Ltd., which was founded in 1992.
He is currently the Chief Executive Officer & Director at Rekah Pharmaceutical Industry Ltd.
and the Chairman & President at Rekah Group.
Mr. Algrably's education includes an undergraduate degree from The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/09/2023 | 1 748 439 ( 15,17% ) | 7 M $ | 31/03/2024 |
Postes actifs de Mordechai Algrably
| Sociétés | Poste | Début |
|---|---|---|
| REKAH PHARMACEUTICAL INDUSTRY LTD. | Chief Executive Officer | 24/08/1993 |
| Rekah Group | Chairman | 28/06/2010 |
| Ophir Ltd. | Founder | 28/06/2010 |
Formation de Mordechai Algrably
| The Hebrew University of Jerusalem | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REKAH PHARMACEUTICAL INDUSTRY LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Rekah Group | |
| Ophir Ltd. |
